Drawing based on the label description. No photo yet.
“Quinapril and Hydrochlorothiazide Tablets, USP 20 mg/12.5 mg are Pink colored, scored, round shaped, biconvex, film-coated tablets debossed with 'D' on scored side and '19' on other side”
D 19 pill
Pill with imprint D 19 is pink, round, 9 mm and has been identified as Quinapril Hydrochloride/Hydrochlorothiazide 20 mg / 12.5 mg. It is used for high blood pressure. It is supplied by Aurobindo Pharma Limited.
Quinapril Hydrochloride/Hydrochlorothiazide 20 mg / 12.5 mg
- Imprint
- D 19
- Strength
- Quinapril Hydrochloride 20 mg / Hydrochlorothiazide 12.5 mg
- Used for
- High blood pressure
- Color
- Pink
- Shape
- Round
- Size
- 9 mm
- Score
- Breaks into 2 pieces
- Form
- Tablet, film coated
- Manufacturer
- Aurobindo Pharma Limited
- Drug class
- ACE inhibitor (blood pressure and heart medicine)
- NDC
- 65862-162, 65862-162-30, 65862-162-90
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
All Quinapril Hydrochloride/Hydrochlorothiazide pills and guides
What is Quinapril Hydrochloride/Hydrochlorothiazide used for?
Quinapril Hydrochloride/Hydrochlorothiazide is used for high blood pressure.
- Medicine type
- ACE inhibitor (blood pressure and heart medicine); thiazide diuretic (water pill)
Official uses from the US prescribing label
Hypertension Quinapril and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with quinapril and hydrochlorothiazide tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly. Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal. Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy. This fixed combination is not indicated for the initial therapy of hypertension (see DOSAGE AND ADMINISTRATION ). In using quinapril and hydrochlorothiazide tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. Available data are insufficient to show that quinapril does not have a similar risk (see WARNINGS: Neutropenia/Agranulocytosis ). Angioedema in Black Patients Black patients receiving ACE inhibitor monotherapy have been reported to have a higher incidence of angioedema compared to non-blacks. It should also be noted that in controlled clinical trials, ACE inhibitors have an effect on blood pressure that is less in black patients than in non-blacks.
From the FDA-approved label on DailyMed (published Apr 30, 2024).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows D and the other side shows 19.
- It is pink, round, 9 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Quinapril Hydrochloride, Hydrochlorothiazide
Inactive: Lactose Monohydrate, Magnesium Carbonate, Crospovidone (120 .mu.m), Povidone K30, Magnesium Stearate, Hypromellose 2910 (3 Mpa.s), Hypromellose 2910 (50 Mpa.s), Hydroxypropyl Cellulose (1600000 Wamw), Polyethylene Glycol 400, Titanium Dioxide, Ferric Oxide Red, Ferric Oxide Yellow
Other pills with imprint D 19
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AA 15
Desipramine 100 mg
Pink, round, 10 mm
Used for depression and ADHD
-
Y05
Venlafaxine Hydrochloride 100 mg
Pink, round, 10 mm
Used for depression and anxiety
-
Y04
Venlafaxine Hydrochloride 75 mg
Pink, round, 9 mm
Used for depression and anxiety
-
Y03
Venlafaxine Hydrochloride 50 mg
Pink, round, 8 mm
Used for depression and anxiety
-
P200
Carbamazepine 200 mg
Pink, round, 10 mm
Used for PTSD and bipolar disorder
-
498
Zolmitriptan 5 mg
Pink, round, 9 mm
Used for migraine